AlzeCure Pharma’s share is listed on Nasdaq First North Premier Growth Market since 28 November 2018.
Important Information about First North
First North is an alternative marketplace operated by an exchange within the Nasdaq group. Companies on First North are not subject to the same rules as companies on the regulated main market. Instead, they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk when investing in a company on First North may therefore be higher than the risks associated with investing in a company on the main market.
All companies with shares traded on First North have a Certified Adviser who monitors that the rules are followed. The Exchange approves the application for admission to trading.